The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase
Open accessAbstract
Tuberculosis and malaria together result in an estimated 5 million deaths annually. The spread of multidrug resistance in the most pathogenic causative agents, Mycobacterium tuberculosis and Plasmodium falciparum, underscores the need to identify active compounds with novel inhibitory properties. Although genetically unrelated, both organisms use a type II fatty-acid synthase system. Enoyl acyl carrier protein reductase (ENR), a key type II enzyme, has been repeatedly validated as an effective antimicrobial target. Using high throughput inhibitor screens with a combinatorial library, we have identified two novel classes of compounds with activity against the M. tuberculosis and P. falciparum enzyme (referred to as InhA and PfENR, respectively). The crystal structure of InhA complexed with NAD+ and one of the inhibitors was determined to elucidate the mode of binding. Structural analysis of InhA with the broad spectrum antimicrobial triclosan revealed a unique stoichiometry where the enzyme contained either a single triclosan molecule, in a configuration typical of other bacterial ENR:triclosan structures, or harbored two triclosan molecules bound to the active site. Significantly, these compounds do not require activation and are effective against wild-type and drug-resistant strains of M. tuberculosis and P. falciparum. Moreover, they provide broader chemical diversity and elucidate key elements of inhibitor binding to InhA for subsequent chemical optimization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Self-citationThe catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Türbachova, I., Eberl, M., Zeidler, J., Lichtenthaler, H. K., et al. (1999) · Science · doi:10.1126/science.285.5433.1573 · Cited by 1,173
A Plastid of Probable Green Algal Origin in Apicomplexan Parasites
Köhler, S., Delwiche, C. F., Denny, P. W., Tilney, L. G., Webster, P., Wilson, R. J. M., Palmer, J. D., & Roos, D. S. (1997) · Science · doi:10.1126/science.275.5305.1485 · Cited by 760
Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum
Waller, R. F., Keeling, P. J., Donald, R. G. K., Striepen, B., Handman, E., Lang-Unnasch, N., Cowman, A. F., Besra, G. S., Roos, D. S., & McFadden, G. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12352 · Cited by 714
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Self-citationPeterson, D. S., Walliker, D., & Wellems, T. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9114 · Cited by 653
A plastid organelle as a drug target in apicomplexan parasites
Fichera, M. E., & Roos, D. S. (1997) · Nature · doi:10.1038/37132 · Cited by 585
Mechanism of Triclosan Inhibition of Bacterial Fatty Acid Synthesis
Heath, R. J., Rubin, J. R., Holland, D. R., Zhang, E., Snow, M. E., & Rock, C. O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11110 · Cited by 542
Molecular basis of triclosan activity
Levy, C. W., Roujeinikova, A., Sedelnikova, S., Baker, P. J., Stuitje, A. R., Slabas, A. R., Rice, D. W., & Rafferty, J. B. (1999) · Nature · doi:10.1038/18803 · Cited by 518
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Self-citationSurolia, N., & Surolia, A. (2001) · Nature Medicine · doi:10.1038/84612 · Cited by 412
Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis
Quemard, A., Sacchettini, J. C., Dessen, A., Vilcheze, C., Bittman, R., Jacobs, W. R., & Blanchard, J. S. (1995) · Biochemistry · doi:10.1021/bi00026a004 · Cited by 373
Self-citationSu, X.-Z., Kirkman, L. A., Fujioka, H., & Wellems, T. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80447-x · Cited by 347
Broad Spectrum Antimicrobial Biocides Target the FabI Component of Fatty Acid Synthesis
Heath, R. J., Yu, Y.-T., Shapiro, M. A., Olson, E., & Rock, C. O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30316 · Cited by 337
Wang, P., Read, M., Sims, P. F. G., & Hyde, J. E. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2821646.x · Cited by 307
Rozwarski, D. A., Vilchèze, C., Sugantino, M., Bittman, R., & Sacchettini, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15582 · Cited by 290
Self-citationVilchèze, C., Morbidoni, H. R., Weisbrod, T. R., Iwamoto, H., Kuo, M., Sacchettini, J. C., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.4059-4067.2000 · Cited by 283
Self-citationCooper, R. A., Ferdig, M. T., Su, X.-Z., Ursos, L. M. B., Mu, J., Nomura, T., Fujioka, H., Fidock, D. A., Roepe, P. D., & Wellems, T. E. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.35 · Cited by 248
Self-citationHeath, R. J., Li, J., Roland, G. E., & Rock, C. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4654 · Cited by 240
A Mechanism of Drug Action Revealed by Structural Studies of Enoyl Reductase
Baldock, C., Rafferty, J. B., Sedelnikova, S. E., Baker, P. J., Stuitje, A. R., Slabas, A. R., Hawkes, T. R., & Rice, D. W. (1996) · Science · doi:10.1126/science.274.5295.2107 · Cited by 239
Inhibition of InhA, the Enoyl Reductase from Mycobacterium tuberculosis, by Triclosan and Isoniazid
Parikh, S. L., Xiao, G., & Tonge, P. J. (2000) · Biochemistry · doi:10.1021/bi0008940 · Cited by 238
Structural basis and mechanism of enoyl reductase inhibition by triclosan
Stewart, M. J., Parikh, S., Xiao, G., Tonge, P. J., & Kisker, C. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2907 · Cited by 225
Perozzo, R., Kuo, M., Sidhu, A. B. S., Valiyaveettil, J. T., Bittman, R., Jacobs, W. R., Fidock, D. A., & Sacchettini, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112000200 · Cited by 213
Self-citationControl Mechanisms for Fatty Acid Synthesis in Mycobacterium Smegmatis
Bloch, K. E. (1977) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470122907.ch1 · Cited by 195
McLeod, R., Muench, S. P., Rafferty, J. B., Kyle, D. E., Mui, E. J., Kirisits, M. J., Mack, D. G., Roberts, C. W., Samuel, B. U., Lyons, R. E., et al. (2001) · International Journal for Parasitology · doi:10.1016/s0020-7519(01)00111-4 · Cited by 185
Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents
Payne, D. J., Miller, W. H., Berry, V., Brosky, J., Burgess, W. J., Chen, E., DeWolf, W. E., Fosberry, A. P., Greenwood, R., Head, M. S., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3118-3124.2002 · Cited by 170
Fidock, D. A., Nomura, T., & Wellems, T. E. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1140 · Cited by 170
Self-citationWard, W. H. J., Holdgate, G. A., Rowsell, S., McLean, E. G., Pauptit, R. A., Clayton, E., Nichols, W. W., Colls, J. G., Minshull, C. A., Jude, D. A., et al. (1999) · Biochemistry · doi:10.1021/bi9907779 · Cited by 161
Acetoacetyl-acyl carrier protein synthase
Jackowski, S., Murphy, C. M., Cronan, J. E., & Rock, C. O. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83280-x · Cited by 140
Preparation and antibacterial activities of new 1,2,3-diazaborine derivatives and analogs
Grassberger, M. A., Turnowsky, F., & Hildebrandt, J. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00374a003 · Cited by 127
Plastids in parasites of humans
McFadden, G. I., & Waller, R. F. (1997) · BioEssays · doi:10.1002/bies.950191114 · Cited by 126
Heerding, D. A., Chan, G., DeWolf, W. E., Fosberry, A. P., Janson, C. A., Jaworski, D. D., McManus, E. C., Miller, W. H., Moore, T. D., Payne, D. J., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00404-8 · Cited by 125
Molecular basis for triclosan activity involves a flipping loop in the active site
Qiu, X., Abdel‐Meguid, S. S., Janson, C. A., Court, R., Smyth, M. G., & Payne, D. J. (1999) · Protein Science · doi:10.1110/ps.8.11.2529 · Cited by 115
Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI)
Miller, W. H., Seefeld, M. A., Newlander, K. A., Uzinskas, I. N., Burgess, W. J., Heerding, D. A., Yuan, C. C.-K., Head, M. S., Payne, D. J., Rittenhouse, S. F., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020050+ · Cited by 113
Second-hand chloroplasts and the case of the disappearing nucleus.
Palmer, J. D., & Delwiche, C. (1996) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.93.15.7432 · Cited by 108
Nishida, I., Kawaguchi, A., & Yamada, M. (1986) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a135614 · Cited by 96
Crystallographic analysis of triclosan bound to enoyl reductase
Roujeinikova, A., Levy, C., Rowsell, S., Sedelnikova, S. E., Baker, P. J., Minshull, C. A., Mistry, A., Colls, J. G., Camble, R., Stuitje, A. R., et al. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3240 · Cited by 93
Tsay, J. T., Rock, C. O., & Jackowski, S. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.2.508-513.1992 · Cited by 89
Hayashi, T., Yamamoto, O., Sasaki, H., Kawaguchi, A., & Okazaki, H. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80050-3 · Cited by 81
Seefeld, M. A., Miller, W. H., Newlander, K. A., Burgess, W. J., Payne, D. J., Rittenhouse, S. F., Moore, T. D., DeWolf, W. E., Keller, P. M., Qiu, X., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00405-x · Cited by 61
Roujeinikova, A., Sedelnikova, S. E., de Boer, G.-J., Stuitje, A. R., Slabas, A. R., Rafferty, J. B., & Rice, D. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30811 · Cited by 57
Molecular Epidemiologic Evaluation of Transmissibility and Virulence of Mycobacterium tuberculosis
Rhee, J. T., Piatek, A. S., Small, P. M., Harris, L. M., Chaparro, S. V., Kramer, F. R., & Alland, D. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1764-1770.1999 · Cited by 54
Self-citation
Cited by
Antimalarial drug discovery: efficacy models for compound screening
Fidock, D. A., Rosenthal, P. J., Croft, S. L., Brun, R., & Nwaka, S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1416 · Cited by 861
Self-citationMycolic Acids: Structures, Biosynthesis, and Beyond
Marrakchi, H., Lanéelle, M.-A., & Daffé, M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.11.011 · Cited by 623
Innovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521
Antituberculosis drugs: Ten years of research
Janin, Y. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.030 · Cited by 485
Kinnings, S. L., Liu, N., Buchmeier, N., Tonge, P. J., Xie, L., & Bourne, P. E. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000423 · Cited by 319
Metadata
- Authors
- Kuo, M. R., Morbidoni, H. R., Alland, D., Sneddon, S. F., Gourlie, B. B., Staveski, M. M., Leonard, M., Gregory, J. S., Janjigian, A. D., Yee, C., Musser, J. M., Kreiswirth, B., Iwamoto, H., Perozzo, R., Jacobs, W. R., Sacchettini, J. C., & Fidock, D. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 23
- Pages
- 20851-20859
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2142907906
- Cited by
- 263
- References
- 45
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.